×
Merck Revenue 2010-2024 | MRK
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Merck revenue for the twelve months ending December 31, 2024 was
$64.168B
, a
6.74% increase
year-over-year.
Merck annual revenue for 2024 was
$64.168B
, a
6.74% increase
from 2023.
Merck annual revenue for 2023 was
$60.115B
, a
1.4% increase
from 2022.
Merck annual revenue for 2022 was
$59.283B
, a
21.72% increase
from 2021.
View More
Merck Revenue 2010-2024 | MRK
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Merck annual revenue for 2024 was
$64.168B
, a
6.74% increase
from 2023.
Merck annual revenue for 2023 was
$60.115B
, a
1.4% increase
from 2022.
Merck annual revenue for 2022 was
$59.283B
, a
21.72% increase
from 2021.
Related Stocks
Company Name
Market
Cap
Eli Lilly (LLY)
$827.9B
Johnson & Johnson (JNJ)
$384.4B
Novo Nordisk (NVO)
$375.8B
AbbVie (ABBV)
$354.6B
Roche Holding AG (RHHBY)
$262.5B
Novartis AG (NVS)
$219.3B
Pfizer (PFE)
$146.8B
Sanofi (SNY)
$137.4B
Bayer (BAYRY)
$22.6B
Innoviva (INVA)
$1.1B